Bell Investment Advisors, Inc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1890149 ORINDA, CA

Position in NBIX

as of Mar 31, 2026 · filed Apr 17, 2026 Compact

Position Value

$8,826

+$3,437 QoQ

Shares Held

+76.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

17 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bell Investment Advisors, Inc holds $125,074 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	41	$24,312
2	RDY	Dr Reddys Laboratories Ltd	1,724	$23,877
3	TAK	Takeda Pharmaceutical Co Ltd	905	$16,760
4	ZTS	Zoetis Inc.	83	$9,811
5	NBIX	Neurocrine Biosciences Inc This page	67	$8,826
6	ELAN	Elanco Animal Health Inc	288	$6,891
7	HLN	Haleon plc	660	$6,606
8	VTRS	Viatris Inc	466	$6,295

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,826	67	+76.3%	Shares	Sole	2026-04-17
2025-12-31	$5,389	38	-9.5%	Shares	Sole	2026-02-24
2025-09-30	$5,895	42	-10.6%	Shares	Sole	2025-11-21
2025-06-30	$5,907	47	+56.7%	Shares	Sole	2025-08-11
2025-03-31	$3,318	30	0.0%	Shares	Sole	2025-05-16
2024-12-31	$4,095	30	+42.9%	Shares	Sole	2025-02-07
2024-09-30	$2,419	21	0.0%	Shares	Sole	2024-11-13
2024-06-30	$2,891	21	0.0%	Shares	Sole	2024-08-08
2024-03-31	$2,896	21	0.0%	Shares	Sole	2024-05-08
2023-12-31	$2,766	21	-30.0%	Shares	Sole	2024-02-14
2023-09-30	$3,375	30	-11.8%	Shares	Sole	2023-11-08
2023-06-30	$3,206	34	-12.8%	Shares	Sole	2023-08-09
2023-03-31	$3,947	39	+14.7%	Shares	Sole	2023-05-10
2022-12-31	$4,060	34	+13.3%	Shares	Sole	2023-02-09
2022-09-30	$3,186	30	0.0%	Shares	Sole	2022-11-09
2022-06-30	$2,924	30	+57.9%	Shares	Sole	2022-08-12
2021-09-30	$1,822	19	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.